Telehealth startup halts controlled substance prescriptions after allegations of overprescribing

Telehealth startup Cerebral is putting a pause on prescribing controlled substances to new patients as the company faces allegations of overprescribing, The Wall Street Journal reported May 4.

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive